These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 30311860)
21. Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: II. Interstitium and microvasculature. Schneider R; Welt K; Aust W; Löster H; Fitzl G Histol Histopathol; 2009 May; 24(5):587-98. PubMed ID: 19283667 [TBL] [Abstract][Full Text] [Related]
22. Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats. Singh A; Randhawa PK; Bali A; Singh N; Jaggi AS Cardiovasc Drugs Ther; 2017 Apr; 31(2):133-143. PubMed ID: 28194544 [TBL] [Abstract][Full Text] [Related]
23. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Tao L; Gao E; Jiao X; Yuan Y; Li S; Christopher TA; Lopez BL; Koch W; Chan L; Goldstein BJ; Ma XL Circulation; 2007 Mar; 115(11):1408-16. PubMed ID: 17339545 [TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharides Improve Mesenchymal Stem Cell-Mediated Cardioprotection by MyD88 and stat3 Signaling in a Mouse Model of Cardiac Ischemia/Reperfusion Injury. Chu X; Xu B; Gao H; Li BY; Liu Y; Reiter JL; Wang Y Stem Cells Dev; 2019 May; 28(9):620-631. PubMed ID: 30808255 [TBL] [Abstract][Full Text] [Related]
25. [The biochemical and cellular bases of myocardial ischemia-reperfusion damage]. Téllez F; Carvajal K; García C; Vásquez C; Chávez E; Moreno-Sánchez R Arch Inst Cardiol Mex; 1996; 66(2):162-81. PubMed ID: 8768635 [TBL] [Abstract][Full Text] [Related]
26. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists. Maslov LN; Khaliulin I; Zhang Y; Krylatov AV; Naryzhnaya NV; Mechoulam R; De Petrocellis L; Downey JM J Cardiovasc Pharmacol Ther; 2016 May; 21(3):262-72. PubMed ID: 26487546 [TBL] [Abstract][Full Text] [Related]
27. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection. Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219 [TBL] [Abstract][Full Text] [Related]
28. Bisoprolol protects myocardium cells against ischemia/reperfusion injury by attenuating unfolded protein response in rats. Zhang C; He S; Li Y; Li F; Liu Z; Liu J; Gong J Sci Rep; 2017 Sep; 7(1):11859. PubMed ID: 28928480 [TBL] [Abstract][Full Text] [Related]
29. Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Meldrum DR; Cleveland JC; Cain BS; Meng X; Harken AH Ann Thorac Surg; 1998 Feb; 65(2):439-43. PubMed ID: 9485242 [TBL] [Abstract][Full Text] [Related]
30. Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemic-reperfusion injury. Yue QX; Xie FB; Song XY; Wu WY; Jiang BH; Guan SH; Yang M; Liu X; Guo DA J Ethnopharmacol; 2012 Jun; 141(2):659-67. PubMed ID: 21903157 [TBL] [Abstract][Full Text] [Related]
34. There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injury. Bell RM; Yellon DM Cardiovasc Ther; 2011 Dec; 29(6):e67-79. PubMed ID: 20645988 [TBL] [Abstract][Full Text] [Related]
35. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. Wischmeyer PE; Jayakar D; Williams U; Singleton KD; Riehm J; Bacha EA; Jeevanandam V; Christians U; Serkova N JPEN J Parenter Enteral Nutr; 2003; 27(6):396-403. PubMed ID: 14621120 [TBL] [Abstract][Full Text] [Related]
36. Vagus nerve stimulation exerts cardioprotection against myocardial ischemia/reperfusion injury predominantly through its efferent vagal fibers. Nuntaphum W; Pongkan W; Wongjaikam S; Thummasorn S; Tanajak P; Khamseekaew J; Intachai K; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K Basic Res Cardiol; 2018 May; 113(4):22. PubMed ID: 29744667 [TBL] [Abstract][Full Text] [Related]
37. "AMP"(K)ed up recovery from ischemia-reperfusion injury. Levi B Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637927 [TBL] [Abstract][Full Text] [Related]
38. [Cardioprotective effects of flokalin in experiments in vivo: influence on hemodynamic and myocardial lesions in ischemia-reperfusion]. Strutyns'kyĭ RB; Neshcheret OP; Tumanovs'ka LV; Rovenets' RA; Moĭbenko OO Fiziol Zh (1994); 2009; 55(5):9-16. PubMed ID: 20095379 [TBL] [Abstract][Full Text] [Related]
39. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Vinten-Johansen J Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479 [TBL] [Abstract][Full Text] [Related]
40. Myocardial angiotensin II receptor expression and ischemia-reperfusion injury. Yang B; Li D; Phillips MI; Mehta P; Mehta JL Vasc Med; 1998; 3(2):121-30. PubMed ID: 9796075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]